ESC Premium Access

Progress in the management of pulmonary hypertension

Event: ESC CONGRESS 2017
Topic: Chronic pulmonary hypertension
Session type: Rapid Fire Abstracts
Date: 29 August 2017
Time: 11:00 - 12:30

Congress Session

10 presentations in this session

Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)

Speaker: Doctor R. Sadushi-Kolici (Vienna, AT)
Thumbnail

A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

Speaker: Doctor H. Farber (Bollington, GB)
Thumbnail

Comparative receptor pharmacology, pre-clinical efficacy and pharmacokinetics of a novel, next-generation prostacyclin receptor agonist, ralinepag (APD811), in humans and rats

Speaker: Doctor J. Adams (San Diego, US)
Thumbnail

Cardiac magnetic resonance characterization of maladaptive right ventricular hypertrophy in chronic pulmonary hypertension.

Speaker: Doctor I. Garcia Lunar (Madrid, ES)
Thumbnail

APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary artery

Speaker: Doctor J. Patel (London, GB)
Thumbnail

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease

Speaker: Miss B. Girerd (Clamart, FR)
Thumbnail

Vagal nerve stimulation ameliorates severe pulmonary arterial hypertension via anti-inflammatory effects in rats

Speaker: Doctor K. Yoshida (Iizuka, JP)
Thumbnail

JAK1/2 inhibitor ruxolitinib restores the responsiveness to hypoxia in pulmonary arterial hypertension-iPSC-derived endothelial cells

Speaker: Mr M. Lachmann (Munich, DE)
Thumbnail

Pulmonary artery aneurysms: prognostic implications in pulmonary arterial hypertension patients.

Speaker: Doctor J. Nuche (Madrid, ES)
Thumbnail

Six-segments right ventricular global longitudinal strain predicts survival in patients with pulmonary hypertension receiving specific vasodilator therapy

Speaker: Doctor R. Enache (Bucharest, RO)
Thumbnail

10 speakers from this session

Doctor Roela Sadushi-Kolici

Medical University of Vienna, Vienna (Austria)
0 follower

Doctor Harrison Farber

Adelphi Communications, Bollington (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor John Adams

Arena, San Diego (United States of America)
0 follower

Doctor Ines Garcia Lunar

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)
0 follower

Doctor Jigisha Patel

, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Miss Barbara Girerd

AP-HP - Hospital Antoine-Beclere, Department of Pneumology , Clamart (France)
0 follower

Doctor Keimei Yoshida

Aso Iizuka Hospital, Iizuka (Japan)
0 follower

Mr Mark Johannes Lachmann

Hospital right the Isar, Munich (Germany)
0 follower

Doctor Jorge Nuche

Spanish National Centre for Cardiovascular Research, Madrid (Spain)
0 follower

Doctor Roxana Enache

Carol Davila University of Medicine and Pharmacy, Prof. Dr. C.C. Iliescu Institute of Cardiovascular, Bucharest (Romania)
0 follower

This platform is supported by

logo Novo Nordisk